Clinical Trial Update: Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 trial evaluating safety and efficacy of Metaglidasen in adults with Type 2 diabetes mellitus suboptimally controlled on insulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metaglidasen

Snippet

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED